Sonnet BioTherapeutic News

Sonnet BioTherapeutic | 8-K: Current report

Mar 11 07:31 ET

Sonnet BioTherapeutic | 8-K: Current report

Mar 6 16:28 ET

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update

Feb 14 07:37 ET

Sonnet BioTherapeutic | 10-Q: Quarterly report

Feb 14 07:31 ET

Sonnet BioTherapeutic | 8-K: Current report

Feb 1 16:23 ET

Sonnet BioTherapeutic | 8-K: Current report

Jan 29 16:21 ET

Sonnet BioTherapeutic | EFFECT: Others

Jan 5 00:00 ET

Sonnet BioTherapeutic | CORRESP: CORRESP

Jan 3 11:43 ET

Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(6.5%)

Jan 2 00:00 ET

Sonnet BioTherapeutic | UPLOAD: Others

Dec 29, 2023 11:43 ET

Sonnet BioTherapeutic | 8-K: Current report

Dec 27, 2023 00:00 ET

Sonnet BioTherapeutic | S-3: Registration statement for specified transactions by certain issuers

Dec 22, 2023 16:31 ET

Sonnet BioTherapeutic | 8-K: Current report

Dec 15, 2023 16:30 ET

Sonnet BioTherapeutic | 8-K: Current report

Dec 14, 2023 17:03 ET

Sonnet BioTherapeutic: FY2023 Annual Report

Dec 14, 2023 17:02 ET

Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(7.6%)

Nov 17, 2023 11:32 ET

Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(6.4%)

Nov 6, 2023 11:35 ET

Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Director Rao Raghu

Oct 27, 2023 20:00 ET

Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Officer Mohan Pankaj

Oct 27, 2023 20:00 ET

Sonnet BioTherapeutic | 424B4: Prospectus

Oct 26, 2023 09:00 ET